TAYLOR BEN R (Chief Financial Officer) reported 1 transaction at RECURSION PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 4/8/2026ACC: 0001712276-26-000003
Officer· Chief Financial Officer
Since Feb 2026
-48.03K
Net shares
Net seller
$149.4K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
48.03K disposed
Non-Derivative Transactions1
Class A Common Stock
Direct
Shares
−48.03K
Price / share
$3.11
Trade value
$149.37K
% of position
4.1%
4/6/2026
1.18M→1.13M
Total
Net shares
−48.03K
Net value
-$149.37K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock Direct | 4/6/2026 | F · Tax Withholding | −48.03K | $3.11 | $149.37K | 4.1% | 1.18M | 1.13M |
| Total | −48.03K | -$149.37K | ||||||
Derivative Transactions0
No derivative transactions reported